English
Specials
    Upgrade
    MoneycontrolBe a PRO
    Moneycontrol PRO
    you are here: HomeNewsBusinessMoneycontrol Research

    Cadila: a formidable play in Covid times and beyond

    Cadila is not only a credible Indian pharma striving for a Covid solution, but on a longer time scale is an interesting watch in the large-cap space witnessing a significant transformation in product portfolio.

    Anubhav Sahu
    September 25, 2020 / 05:47 PM IST
    Cadila: a formidable play in Covid times and beyond

    PRO Only Highlights
    -      Quarterly performance largely backed by improved realisations
    -      Medium-term triggers China plus and protectionist measures for tyre industry
    -      Valuations not inexpensive; but improved medium-term outlook

    Highlights - Cadila’s Covid vaccine undergoing phase II trials; seeking a range of options - Strong foray into injectables, biologics – a key watch - R&D expense of 7-8 percent of sales heavily allocated for biosimilars - Growing India presence provides stable cash flow visibility Cadila Healthcare (CMP: Rs 376, Market cap: Rs 38,497 crore), known to be one of India’s formidable plays on Covid solutions is a worth a watch, even after the fading of the hydroxychloroquine (HCQS) opportunity. HCQS, which was touted as an early solution...

    • PRO Panorama

      Moneycontrol Pro Panorama | It all starts and ends in the bond market

      Mar 31, 2023 / 03:20 PM IST

      In today’s edition of Moneycontrol Pro Panorama: India's growing gaming market needs better policies, the only solution to the b...

      Read Now
    • PRO Weekender

      Moneycontrol Pro Weekender: Between the Fed and a hard place

      Mar 11, 2023 / 11:38 AM IST

      The Fed is caught between combating inflation and worries over a financial mishap

      Read Now

    To read the full story, Subscribe to Moneycontrol PRO

    Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

    View Plans

    Already a member? Sign in

    Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

    50% OFF

    What Do You Get

    • Ad free experience

      Experience a non-intrusive navigation and faster response in the ad free mode

    • Sharpest Opinions

      Access to 230+ exclusive stories per month from our editorial and Experts

    • +

      Have a Global edge with access to content from world renowned experts and journalist

    • Actionable Insights

      Access to 40+ weekly investment ideas including 4 daily technical calls

    • Virtual Events

      Exclusive access to live webinars from market experts on trading and investment strategies

    • Newsletters

      Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

    View Offers

    Get upto 50% discount on limited period offers